Pentacel Gets Advisory Committee Nod After Data Concerns
Executive Summary
Despite concerns about the availability of sufficient data supporting Pentacel's efficacy against Haemophilus influenzae type b, FDA's Vaccines and Related Biological Products Advisory Committee unanimously recommended approval of the Sanofi-Pasteur combination vaccine